![Cash flow / Generally Accepted Accounting Principles / Financial statements / Cash flow statement / Financial services / Funds / Microbicides for sexually transmitted diseases / Docetaxel / Operating cash flow / Finance / Accountancy / Business Cash flow / Generally Accepted Accounting Principles / Financial statements / Cash flow statement / Financial services / Funds / Microbicides for sexually transmitted diseases / Docetaxel / Operating cash flow / Finance / Accountancy / Business](https://www.pdfsearch.io/img/2b176725cb1f6b0f010d2eb327c67c40.jpg) Date: 2015-01-27 18:08:03Cash flow Generally Accepted Accounting Principles Financial statements Cash flow statement Financial services Funds Microbicides for sexually transmitted diseases Docetaxel Operating cash flow Finance Accountancy Business | | Quarterly Cashflow Report Melbourne, Australia; 28 January 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 December[removed]The cAdd to Reading ListSource URL: www.starpharma.comDownload Document from Source Website File Size: 322,29 KBShare Document on Facebook
|